Decatur Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-51,668
Closed -$8.81M 52
2018
Q1
$8.81M Sell
51,668
-1,532
-3% -$281K 1.82% 26
2017
Q4
$9.25M Buy
+53,200
New +$9.42M 1.87% 28
2017
Q2
Sell
-56,327
Closed -$9.24M 50
2017
Q1
$9.24M Sell
56,327
-17,273
-23% -$2.87M 1.8% 33
2016
Q4
$10.8M Sell
73,600
-12,195
-14% -$1.84M 1.55% 38
2016
Q3
$14.3M Buy
85,795
+2,375
+3% +$402K 1.79% 22
2016
Q2
$12.7M Sell
83,420
-3,500
-4% -$544K 1.71% 32
2016
Q1
$13M Sell
86,920
-150
-0.2% -$22.3K 1.71% 33
2015
Q4
$14.1M Sell
87,070
-16,150
-16% -$2.54M 1.81% 22
2015
Q3
$14.3M Buy
103,220
+17,375
+20% +$2.74M 1.95% 17
2015
Q2
$13.2M Sell
85,845
-31,775
-27% -$5.09M 1.64% 33
2015
Q1
$18.8M Buy
117,620
+3,450
+3% +$543K 2.33% 13
2014
Q4
$18.2M Buy
114,170
+52,870
+86% +$8.24M 2.43% 13
2014
Q3
$8.61M Buy
61,300
+12,075
+25% +$1.58M 1.45% 34
2014
Q2
$5.83M Sell
49,225
-500
-1% -$57.9K 1.1% 41
2014
Q1
$6.13M Buy
49,725
+21,875
+79% +$2.65M 1.17% 41
2013
Q4
$3.18M Sell
27,850
-1,125
-4% -$128K 0.61% 71
2013
Q3
$3.24M Sell
28,975
-20,725
-42% -$2.25M 0.68% 62
2013
Q2
$4.9M Buy
+49,700
New +$5.16M 1.7% 25

Other funds holding AMGN

Decatur Capital Management's AMGN Position: Q2 2018 in Review

Decatur Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 51,668 shares — an estimated $8.81M sold.

Decatur Capital Management first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $18.8M in Q1 2015. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Decatur Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Decatur Capital Management sold 51,668 Amgen shares in Q2 2018, an estimated $8.81M.
  • Decatur Capital Management first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
  • Decatur Capital Management's Amgen position peaked at $18.8M in Q1 2015.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Decatur Capital Management's 13F filing for Q2 2018, filed 1 Aug 2018.